Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

GranuFlo and NaturaLyte Dialysis Drugs Named in Wrongful Death Lawsuit

Filed September 28th, 2012 Laurie

A Georgia man who alleges that his mother died of a major cardiovascular event after being treated with GranuFlo and NaturaLyte acid concentrates is suing Fresenius, the maker of the dialysis treatments.

The lawsuit was filed on September 14 by Waddell Bishop and seeks wrongful death benefits against Fresenius USA and its subsidiaries for the loss of his deceased mother, Frances Carol Bishop.

Frances Carol Bishop suffered a major cardiac event and died on September 16, 2010, after being treated with after receiving dialysis treatment that allegedly included the use of Granuflo or NaturaLyte. The lawsuit alleges that Frances’ death was caused by side effects of the Fresenius products. The complaint also alleges that Fresenius failed to adequately warn patients and medical professionals about the cardiac risks associated with the drugs.

There have been a growing number of dialysis treatment-related lawsuits filed across the U.S. on behalf of patients who died or suffered catastrophic injuries as a result of a cardiac arrest, heart attack or stroke that occurred during or shortly after hemodialysis where Granuflo or NaturaLyte were used.

More than a year after Frances Bishop died, the company issued a detailed internal memo concerning the risk of dialysis problems with GranuFlo and NaturaLyte. The company also shared that that an internal review of patients treated at 667 Fresenius clinics revealed at least 941 instances where patients suffered cardiac arrest during dialysis treatments in 2010.

Bishop is seeking compensatory damages, as well as punitive damages to punish Fresenius as a result of allegedly reckless actions and inactions, which exposed Frances Carol Bishop and other dialysis patients to a serious and life-threatening risk.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!